The T Allele of the Hepatic Lipase Promoter Variant C−480T Is Associated With Increased Fasting Lipids and HDL and Increased Preprandial and Postprandial LpCIII:B
- 1 February 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 19 (2) , 303-308
- https://doi.org/10.1161/01.atv.19.2.303
Abstract
—The common C−480T transition in the hepatic lipase (HL) promoter has been shown to be associated with lower HL activity and increased high density lipoprotein (HDL) cholesterol. We examined the frequency and lipid associations of this HL polymorphism in 385 healthy, young (18- to 28-year-old) men whose fathers had had a premature myocardial infarction (designated cases) and 405 age-matched controls. These individuals were participants in the European Atherosclerosis Research Study II postprandial trial, who had been recruited from 11 European countries in 4 regions (the Baltic; United Kingdom; and central and southern Europe). Overall, the frequency of the T allele was 0.207 in controls and 0.244 in cases ( P =0.08). The T allele was associated with higher fasting plasma total cholesterol ( P P P T allele compared with those homozygous for the C allele ( P T allele, with homozygotes having 23% and 27% higher levels preprandially and postprandially, respectively, than those homozygous for the C allele ( P <0.05). Thus, our results demonstrate that the C−480T polymorphism in the HL promoter is associated with alterations in plasma lipids and lipoproteins and the accumulation of atherogenic LpC-III:B particles.Keywords
This publication has 20 references indexed in Scilit:
- Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistanceAtherosclerosis, 1995
- Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart diseaseAtherosclerosis, 1994
- Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDLBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Quantitative Determination of Different Apolipoprotein B Containing Lipoproteins by an Enzyme Linked Immunosorbent Assay: Apo B with Apo C-III and Apo B with Apo EJournal of Immunoassay, 1991
- Plasma lipoproteins in familial hepatic lipase deficiency.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Inhibition of hepatic lipase activity impairs chylomicron remnant-removal in ratsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Selective degradation of the high density lipoprotein‐2 subfraction by heparin‐releasable liver lipaseFEBS Letters, 1981
- Heparin-releasable (liver) lipase(s) may play a role in the uptake of cholesterol by steroid-secreting tissuesTrends in Biochemical Sciences, 1980
- Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in manAtherosclerosis, 1980
- Effect of serum and C‐apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipaseFEBS Letters, 1976